Valion Bio VBIO
NASDAQ VBIO
$0.96 -0.16 (-14.29%)
At close: Oct 22, 2026 · 4:00 PM EDT

Valion Bio (VBIO) Times Interest Earned (2021 - 2026)

Updated

Valion Bio's Times Interest Earned was -9.30 in Q2 2026.

Analysis

Valion Bio (VBIO) Times Interest Earned (2021 - 2026) Analysis & Trends

On a trailing twelve-month basis, Valion Bio's Times Interest Earned was -10.57 through Jun 30, 2026; for FY2025, it came in at -54.10.

  • The Q2 2026 figure marks the highest quarterly Times Interest Earned since Q2 2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Eli Lilly 1,144.36 Bn 1,112.95 Bn 19.71 Bn -
2 Johnson & Johnson 635.36 Bn 555.22 Bn 17.30 Bn 28.50
3 AbbVie 502.79 Bn 475.90 Bn 12.70 Bn -
4 Merck 356.08 Bn 310.46 Bn 12.21 Bn -
5 Novartis Ag 300.87 Bn 264.86 Bn 11.24 Bn 10.28
6 Astrazeneca 264.31 Bn 237.99 Bn 12.86 Bn 7.27
7 Amgen 239.07 Bn 194.47 Bn 7.24 Bn 5.22
8 Gilead Sciences 194.50 Bn 168.70 Bn 6.22 Bn -42.08
9 Pfizer 171.00 Bn 117.64 Bn 10.94 Bn -
10 Valion Bio 125,763.04 -19.31 Mn - -9.30
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -9.30
Jun 30, 2021 -4.73
Mar 31, 2021 -3.86
API Access

Valion Bio Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=VBIO&period=max&api_key=YOUR_API_KEY